111 related articles for article (PubMed ID: 9492274)
1. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor.
Noorman F; Barrett-Bergshoeff MM; Rijken DC
Eur J Biochem; 1998 Jan; 251(1-2):107-13. PubMed ID: 9492274
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
3. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
[TBL] [Abstract][Full Text] [Related]
5. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
[TBL] [Abstract][Full Text] [Related]
7. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
Noorman F; Braat EA; Rijken DC
Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
[TBL] [Abstract][Full Text] [Related]
8. Binding of tissue-type plasminogen activator by the mannose receptor.
Otter M; Barrett-Bergshoeff MM; Rijken DC
J Biol Chem; 1991 Jul; 266(21):13931-5. PubMed ID: 1906888
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
[TBL] [Abstract][Full Text] [Related]
10. Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration.
Biessen EA; Noorman F; van Teijlingen ME; Kuiper J; Barrett-Bergshoeff M; Bijsterbosch MK; Rijken DC; van Berkel TJ
J Biol Chem; 1996 Nov; 271(45):28024-30. PubMed ID: 8910412
[TBL] [Abstract][Full Text] [Related]
11. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells.
Nguyen G; Self SJ; Camani C; Kruithof EK
J Biol Chem; 1992 Mar; 267(9):6249-56. PubMed ID: 1313432
[TBL] [Abstract][Full Text] [Related]
13. alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.
Hajjar KA; Reynolds CM
J Clin Invest; 1994 Feb; 93(2):703-10. PubMed ID: 8113404
[TBL] [Abstract][Full Text] [Related]
14. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
Stang E; Roos N; Schlüter M; Berg T; Krause J
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
Rijken DC; Otter M; Kuiper J; van Berkel TJ
Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
[TBL] [Abstract][Full Text] [Related]
17. Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
Lansink M; Jong M; Bijsterbosch M; Bekkers M; Toet K; Havekes L; Emeis J; Kooistra T
Blood; 1999 Aug; 94(4):1330-6. PubMed ID: 10438721
[TBL] [Abstract][Full Text] [Related]
18. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206.
Feinberg H; Jégouzo SAF; Lasanajak Y; Smith DF; Drickamer K; Weis WI; Taylor ME
J Biol Chem; 2021; 296():100368. PubMed ID: 33545173
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
